Periventricular nucleus lesioning modulates specific somatostatin binding in various brain regions and anterior pituitary.
The effects of periventricular nucleus (Pe) lesioning on the plasma growth hormone (GH) levels and the anterior pituitary (A.P.) and brain somatostatin (SRIF) receptors were studied. A transient significant increase in plasma GH level in lesioned rats was detected 1 day after the operation. This elevated level of plasma GH started to decrease 3 days after lesioning. These changes were paralleled by an increase in binding of 125I-Tyr11-SRIF-14 to the A.P. 1 day after lesioning. This result could further confirm that the SRIF inhibitory action on GH release takes place at the A.P. level. Also, a transient increase in binding of the radioligand was detected in some brain areas 1 and 4 days after the lesion. However, the mechanism by which this increase takes place remains to be elucidated.
Sabry
I
I
Zoology Department, Faculty of Science, Alexandria University, Egypt.
Suzuki
M
M
Shigematsu
K
K
Kakegawa
T
T
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004558:Electric Stimulation; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism* / Q000473:pathology; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013004:Somatostatin / Q000097:blood / Q000378:metabolism*
D017481:Receptors, Somatostatin; D013004:Somatostatin